Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Wegovy is a prescription-only medication and therefore cannot be accessed or purchased without approval from a registered pharmacist or health care professional
Its active compounds enhance GLP-1 secretion from intestinal L-cells while increasing GLP-1 receptor sensitivity, helping improve glucose metabolism, reduce lipid accumulation, and support weight management through activation of important metabolic pathways like AMPK-signaling
Both the Wegovy pill and injections contain the same active ingredient, semaglutide, and are approved for adults living with obesity (a body mass index (BMI) of 30 or more) or those who are overweight (BMI between 27 and 30) with at least one weight-related health condition
With over 11 million Canadians living with diabetes or prediabetes, and millions more affected by obesity, the potential impact is significant
